You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
While its announcement of a new low-cost sequencing platform caused one blogger to lose some sleep, Illumina has Forbes' Matthew Herper contemplating the consequences of the Life Technologies Ion Personal Genome Machine's new competition within the sequencing market.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.
A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.
In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.
According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.